Figure S2 from APTO-253 Is a New Addition to the Repertoire of Drugs that Can Exploit DNA BRCA1/2 Deficiency

Authors :: Stephen B. Howell
William G. Rice
Larry A. Gross
Yongxuan Su
Andrea Local
Hongying Zhang
Si Sun
Cheng-Yu Tsai
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: The accumulation of phospho-ATM, γ-H2AFX and cleaved PARP in Raji compared to that in Raji/253R cells exposed to APTO-253 for 24 h.

Full Text Access

Tools